Cite
HARVARD Citation
Oaknin, A. et al. (n.d.). 2022-LBA-325-ESGO Patients with newly diagnosed ovarian cancer treated with maintenance rucaparib: exploratory biomarker analysis from the phase 3 ATHENA-MONO study (GOG-3020/ENGOT-ov45; NCT03522246). International journal of gynecological cancer. p. A472. [Online].